CORC

在结果中检索

CORC

浏览/检索结果: 共118条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Research on the properties of Ta2O5optical films prepared with APS plasma assisted deposition 会议论文
Shanghai, China, 2021-10-28
作者:  Pan, Yong-Gang;  Liu, Zheng;  Liu, Wen-Cheng;  Li, Mian;  Zhang, Si-Bao
收藏  |  浏览/下载：64/0  |  提交时间：2022/03/18
Research on the properties of HfO2optical films prepared with APS assisted electron beam evaporation deposition 会议论文
Hangzhou, China, 2021-05-23
作者:  Pan, Yong-Gang;  Liu, Zheng;  Li, Mian;  Liu, Wen-Cheng;  Bai, Long
收藏  |  浏览/下载：47/0  |  提交时间：2021/09/14
Towards microfluidic-based optical encryption using superhydrophobic surfaces created by femtosecond laser ablation 会议论文
Jiaxing, China, July 27-31, 2021
作者:  Zheng JC(郑建辰);  Yu HB(于海波);  Wen YD(文扬东);  Zhao WX(赵文秀);  Luo H(罗昊)
收藏  |  浏览/下载：8/0  |  提交时间：2021/11/27
Computational phase microscopy with modulated illumination 会议论文
Beijing, China, 2019-10-26
作者:  Gao, Peng;  Wen, Kai;  Liu, Lixin;  Zheng, Juanjuan
收藏  |  浏览/下载：25/0  |  提交时间：2020/04/23
Mapping diffuse emission in lyman UV band 会议论文
Virtual, Online, CA, United states, 2020-12-14
作者:  Ji, Li;  Lou, Zheng;  Zhang, Jinlong;  Qiu, Keqiang;  Li, Shuangying
收藏  |  浏览/下载：68/0  |  提交时间：2021/02/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
Exploiting Local Feature Patterns for Unsupervised Domain Adaptation 会议论文
THIRTY-THIRD AAAI CONFERENCE ON ARTIFICIAL INTELLIGENCE / THIRTY-FIRST INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE / NINTH AAAI SYMPOSIUM ON EDUCATIONAL ADVANCES IN ARTIFICIAL INTELLIGENCE, 2019-01-01
作者:  Wen, Jun;  Liu, Risheng;  Zheng, Nenggan;  Zheng, Qian;  Gong, Zhefeng
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
Cross-fiber spatial-temporal co-enhanced networks for video action recognition 会议论文
作者:  Wu, Haoze;  Chen, Zhenzhong;  Zha, Zheng-Jun;  Liu, Dong;  Wen, Xin
收藏  |  浏览/下载：13/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace